REGENERON PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tarrytown, NY
SEC filing record 1 source field available
Fiscal year end
31 December
REGENERON PHARMACEUTICALS, INC. has filed 2,468 SEC EDGAR filings since 26 Jul 1995

SEC filing history

Showing 51-75 of 205 matching filings.

Per page
25
Current page
3
8-K File 000-19034

8-K filing

Filing date
19 Jun 2019
Reporting date
14 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-19034

8-K/A filing

Filing date
07 May 2019
Reporting date
07 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K

Filing date
07 May 2019
Reporting date
07 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K filing

Filing date
03 May 2019
Reporting date
02 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K filing

Filing date
10 Apr 2019
Reporting date
08 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

FORM 8-K

Filing date
06 Feb 2019
Reporting date
06 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-19034

8-K

Filing date
07 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .